Analysis of genomic drivers of discordant risk classifications in #ProstateCancer. Michael Zelefsky, MD NYU Langone Health joins Dan Spratt, MD Case Comprehensive Cancer Center discussing an extensive genomic profiling analysis, examining over 200,000 prostate biopsies to illuminate discordances between traditional NCCN risk groups and #Decipher genomic classifier scores. #WatchNow > bit.ly/3KELs95 Decipher by Veracyte | UroToday